UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) by 2.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,444,703 shares of the real estate investment trust's stock after acquiring an additional 40,127 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.61% of Sabra Health Care REIT worth $25,022,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also made changes to their positions in SBRA. Barclays PLC lifted its holdings in shares of Sabra Health Care REIT by 56.1% in the 3rd quarter. Barclays PLC now owns 678,397 shares of the real estate investment trust's stock valued at $12,624,000 after buying an additional 243,895 shares during the period. Bank of New York Mellon Corp lifted its holdings in shares of Sabra Health Care REIT by 13.0% in the 4th quarter. Bank of New York Mellon Corp now owns 4,039,651 shares of the real estate investment trust's stock valued at $69,967,000 after buying an additional 463,601 shares during the period. Jefferies Financial Group Inc. acquired a new position in shares of Sabra Health Care REIT in the 4th quarter valued at about $348,000. abrdn plc lifted its holdings in shares of Sabra Health Care REIT by 2.9% in the 4th quarter. abrdn plc now owns 900,690 shares of the real estate investment trust's stock valued at $15,600,000 after buying an additional 25,195 shares during the period. Finally, ExodusPoint Capital Management LP lifted its holdings in shares of Sabra Health Care REIT by 66.9% in the 4th quarter. ExodusPoint Capital Management LP now owns 917,166 shares of the real estate investment trust's stock valued at $15,885,000 after buying an additional 367,777 shares during the period. 99.40% of the stock is currently owned by hedge funds and other institutional investors.
Insider Buying and Selling at Sabra Health Care REIT
In other news, Director Michael J. Foster sold 11,000 shares of the business's stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $18.22, for a total transaction of $200,420.00. Following the sale, the director now owns 64,725 shares of the company's stock, valued at $1,179,289.50. The trade was a 14.53% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.10% of the stock is owned by corporate insiders.
Wall Street Analyst Weigh In
SBRA has been the subject of a number of analyst reports. Truist Financial upped their price target on Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a "hold" rating in a report on Tuesday, March 18th. Scotiabank upped their price target on Sabra Health Care REIT from $18.00 to $19.00 and gave the stock a "sector perform" rating in a report on Monday, May 12th. Three analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $19.50.
Read Our Latest Stock Report on Sabra Health Care REIT
Sabra Health Care REIT Stock Up 0.4%
NASDAQ SBRA traded up $0.07 during trading on Friday, reaching $17.49. 2,221,737 shares of the company's stock were exchanged, compared to its average volume of 2,222,123. The stock has a market cap of $4.16 billion, a P/E ratio of 33.00, a price-to-earnings-growth ratio of 1.97 and a beta of 0.88. The company has a debt-to-equity ratio of 0.88, a quick ratio of 4.16 and a current ratio of 4.32. The company has a 50 day moving average price of $17.54 and a two-hundred day moving average price of $17.31. Sabra Health Care REIT, Inc. has a 1 year low of $13.87 and a 1 year high of $20.03.
Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last posted its earnings results on Monday, May 5th. The real estate investment trust reported $0.37 EPS for the quarter, topping analysts' consensus estimates of $0.36 by $0.01. Sabra Health Care REIT had a return on equity of 4.60% and a net margin of 18.02%. The business had revenue of $183.54 million for the quarter, compared to analysts' expectations of $180.23 million. During the same quarter in the previous year, the firm earned $0.35 earnings per share. The business's revenue was up 10.1% compared to the same quarter last year. On average, equities research analysts anticipate that Sabra Health Care REIT, Inc. will post 1.45 EPS for the current fiscal year.
Sabra Health Care REIT Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, May 30th. Shareholders of record on Friday, May 16th were issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 6.86%. The ex-dividend date of this dividend was Friday, May 16th. Sabra Health Care REIT's dividend payout ratio is presently 203.39%.
Sabra Health Care REIT Profile
(
Free Report)
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
Featured Stories

Before you consider Sabra Health Care REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Health Care REIT wasn't on the list.
While Sabra Health Care REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.